ViroGates A/S (CPH:VIRO)
Denmark · Delayed Price · Currency is DKK 7.80
-0.30 (-3.70%)
Nov 6, 2026, 5:00 PM CET
ViroGates Market Cap
ViroGates has a market cap or net worth of 72.4 million as of November 6, 2026. It is the 40,643rd most valuable company in the world and the 115th biggest in Denmark. Its market cap has decreased by 28.55% in one year.
Market Cap
72.40M
Enterprise Value
58.70M
Revenue
9.36M
Global Rank
Country Rank
#115 Denmark
PE Ratio
n/a
ChartMarket Cap Chart
Since June 26, 2018, ViroGates's market cap has decreased from 259.22M to 72.40M, a decrease of -72.07%. That is a compound annual growth rate of -14.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 72.40M | -42.01% |
| Dec 30, 2025 | 124.84M | 52.27% |
| Dec 30, 2024 | 81.99M | 111.23% |
| Dec 29, 2023 | 38.81M | -71.09% |
| Dec 30, 2022 | 134.25M | -70.57% |
| Dec 30, 2021 | 456.12M | 79.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.18T |
| Genmab | 206.27B |
| Coloplast | 113.80B |
| Demant | 78.50B |
| Gubra | 4.77B |
| BioPorto | 495.11M |
| Pharma Equity Group | 83.47M |
| Scandinavian Medical Solutions | 77.02M |